Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

IR-contact

 

 

 

Karl Hård, Head of Investor Relations & Communications
[email protected] Phone: +46 733 011 944

Nicklas Westerholm, CEO
[email protected]

Yilmaz Mahshid, CFO
[email protected]

Calendar and upcoming reports

December 3, 2024
Redeye Technology & Life Science Day (Stockholm & online)

December 18, 2024
Investor Day

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: [email protected]